# Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation

> **NCT02784093** · PHASE2 · UNKNOWN · sponsor: **Jinling Hospital, China** · enrollment: 83 (actual)

## Conditions studied

- Fecal Impaction

## Interventions

- **DRUG:** Gastrografin
- **PROCEDURE:** enemas

## Key facts

- **NCT ID:** NCT02784093
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784093, "Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02784093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*